ADMA

ADMA Biologics, Inc.NASDAQHealthcare

$9.19+0.88%ClosedMarket Cap: $2.19B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-26	Cantor Fitzgerald	—	Neutral	—
2025-05-08	Raymond James	—	Strong Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$1.28	$778.5M	1
Sun Dec 31	$1.62	$944.9M	2
Mon Dec 31	$2.01	$1.13B	1
Tue Dec 31	$2.30	$1.26B	1